NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-1,415 Cr | ₹-1,033 Cr | ₹-477 Cr | ₹-5.30 Cr | ₹-103 Cr |
What is the latest Cash Flow from Investing Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-1,415 Cr |
| Mar2024 | ₹-1,033 Cr |
| Mar2023 | ₹-477 Cr |
| Mar2022 | ₹-5.30 Cr |
| Mar2021 | ₹-103 Cr |
How is Cash Flow from Investing Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,415 Cr | Negative | |
| Mar2024 | ₹-1,033 Cr | Negative | |
| Mar2023 | ₹-477 Cr | Negative | |
| Mar2022 | ₹-5.30 Cr | Negative | |
| Mar2021 | ₹-103 Cr | - | |
Compare Cash Flow from Investing Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹20,271.4 Cr | -3.5% | 1.2% | 41.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -3.5% |
1.2% |
41.1% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses